The unsatisfactory chemotherapeutic effect of TMZ is due to more than 50% of GBM patients being resistant to TMZ [64], mainly due to the high expression of O-6-methylguanine-DNA methyltransferase (MGMT), which alters methylation and preserves tumor cells [65]. Here, MGMT is linked to glioblastoma.